Literature DB >> 23175127

A novel GATA5 loss-of-function mutation underlies lone atrial fibrillation.

Xin-Hua Wang1, Cong-Xin Huang, Qian Wang, Ruo-Gu Li, Ying-Jia Xu, Xu Liu, Wei-Yi Fang, Yi-Qing Yang.   

Abstract

Atrial fibrillation (AF), the most common sustained cardiac arrhythmia, is associated with significantly increased morbidity and mortality. Cumulative evidence highlights the importance of genetic defects in the pathogenesis of AF. However, AF is of remarkable heterogeneity and the genetic determinants of AF in a vast majority of patients remain illusive. In this study, the coding exons and splice junctions of the GATA5 gene, which encodes a zinc-finger transcription factor essential for normal cardiogenesis, were sequenced in 118 unrelated patients with lone AF. The available relatives of the index patient carrying an identified mutation and 200 unrelated ethnically-matched healthy individuals used as controls were genotyped. The functional effect of the mutant GATA5 was characterized in contrast to its wild-type counterpart using a luciferase reporter assay system. As a result, a novel heterozygous GATA5 mutation, p.W200G, was identified in a family with AF inherited as an autosomal dominant trait. The mutation was absent in 200 control individuals and the altered amino acid was completely conserved evolutionarily across species. Functional analysis showed that the mutation of GATA5 was associated with a significantly decreased transcriptional activity. These findings provide novel insight into the molecular mechanism involved in AF, suggesting potential implications for the early prophylaxis and gene-specific therapy of AF.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23175127     DOI: 10.3892/ijmm.2012.1189

Source DB:  PubMed          Journal:  Int J Mol Med        ISSN: 1107-3756            Impact factor:   4.101


  13 in total

Review 1.  Emerging directions in the genetics of atrial fibrillation.

Authors:  Nathan R Tucker; Patrick T Ellinor
Journal:  Circ Res       Date:  2014-04-25       Impact factor: 17.367

Review 2.  Genetics of atrial fibrillation: from families to genomes.

Authors:  Ingrid E Christophersen; Patrick T Ellinor
Journal:  J Hum Genet       Date:  2015-05-21       Impact factor: 3.172

3.  Novel and functional DNA sequence variants within the GATA5 gene promoter in ventricular septal defects.

Authors:  Ji-Ping Shan; Xiao-Li Wang; Yuan-Gang Qiao; Hong-Xin Wan Yan; Wen-Hui Huang; Shu-Chao Pang; Bo Yan
Journal:  World J Pediatr       Date:  2014-12-17       Impact factor: 2.764

Review 4.  Atrial Fibrillation Genomics: Discovery and Translation.

Authors:  David H Yoo; Rolf Bodmer; Karen Ocorr; Christopher J Larson; Alexandre R Colas; Evan D Muse
Journal:  Curr Cardiol Rep       Date:  2021-10-01       Impact factor: 2.931

Review 5.  Genomics of Atrial Fibrillation.

Authors:  Alejandra Gutierrez; Mina K Chung
Journal:  Curr Cardiol Rep       Date:  2016-06       Impact factor: 2.931

6.  Genetic Discoveries in Atrial Fibrillation and Implications for Clinical Practice.

Authors:  Saagar Mahida
Journal:  Arrhythm Electrophysiol Rev       Date:  2014-08-30

Review 7.  Genetics of atrial fibrillation.

Authors:  Jitae A Kim; Mihail G Chelu; Na Li
Journal:  Curr Opin Cardiol       Date:  2021-05-01       Impact factor: 2.161

8.  Atrial fibrillation.

Authors: 
Journal:  Nat Rev Dis Primers       Date:  2016-03-31       Impact factor: 65.038

9.  Mutational spectrum of the NKX2-5 gene in patients with lone atrial fibrillation.

Authors:  Hong Yu; Jia-Hong Xu; Hao-Ming Song; Lan Zhao; Wen-Jun Xu; Juan Wang; Ruo-Gu Li; Lei Xu; Wei-Feng Jiang; Xing-Biao Qiu; Jin-Qi Jiang; Xin-Kai Qu; Xu Liu; Wei-Yi Fang; Jin-Fa Jiang; Yi-Qing Yang
Journal:  Int J Med Sci       Date:  2014-04-07       Impact factor: 3.738

10.  GATA5 mutation homozygosity linked to a double outlet right ventricle phenotype in a Lebanese patient.

Authors:  Kameel Kassab; Hadla Hariri; Lara Gharibeh; Akl C Fahed; Manal Zein; Inaam El-Rassy; Mona Nemer; Issam El-Rassi; Fadi Bitar; Georges Nemer
Journal:  Mol Genet Genomic Med       Date:  2015-12-20       Impact factor: 2.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.